BNGO Bionano Genomics, Inc.

Nasdaq bionanogenomics.com


$ 2.07 $ 0.13 (6.63 %)    

Tuesday, 14-Oct-2025 18:01:35 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 2.09
$ 1.94
$ 2.06 x 100
$ 2.14 x 4,510
$ 1.91 - $ 2.12
$ 1.50 - $ 22.80
555,751
na
9.78M
$ 2.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-05-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-23-2021 12-31-2020 10-K
20 11-13-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 06-18-2020 03-31-2020 10-Q
23 03-10-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-14-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-bionano-genomics-bngo-stock-is-getting-hammered-tuesday

BioNano Genomics shares are trading sharply lower in Tuesday's session. The company announced the pricing of a $10 million ...

 bionano-genomics-prices-10m-public-offering-of-5m-shares-and-series-warrants-at-a-combined-price-of-200-could-potentially-earn-20m-from-warrant-exercises

Bionano Genomics, Inc. (NASDAQ:BNGO) ("Bionano" or the "Company") today announced the pricing of a public offer...

 bionano-genomics-selected-for-sole-source-contract-by-nih-for-optical-genome-mapping-reagents-and-instruments-no-contract-value-disclosed

https://sam.gov/opp/7a19a6e8954c4de1a128b841e2018400/view DescriptionThis is a notice of intent, not a request for a quotation....

 hc-wainwright--co-maintains-buy-on-bionano-genomics-raises-price-target-to-11

HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and raises the price target from...

 bionano-genomics-q2-eps-199-beats-242-estimate-sales-6733m-miss-6832m-estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.99) per share which beat the analyst consensus estimate of $(2....

 bionano-genomics-affirms-fy2025-sales-guidance-of-26000m-30000m-vs-29363m-est

Bionano Genomics (NASDAQ:BNGO) affirms FY2025 sales outlook from $26.000 million-$30.000 million to $26.000 million-$30.000 mil...

 bionano-genomics-sees-q3-sales-6700m-7200m-vs-7661m-est

Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $6.700 million-$7.200 million vs $7.661 million analyst estimate.

 bionano-genomics-announces-peer-reviewed-study-showing-that-optical-genome-mapping-can-effectively-detect-oncogenic-structural-variants-in-infant-and-toddler-t-cell-acute-lymphoblastic-leukemia

Bionano Genomics, Inc. (NASDAQ:BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Inst...

 maxim-group-upgrades-bionano-genomics-to-buy-announces-8-price-target

Maxim Group analyst Jason McCarthy upgrades Bionano Genomics (NASDAQ:BNGO) from Hold to Buy and announces $8 price target.

 bionano-genomics-lowers-fy2025-sales-guidance-from-2900m-3200m-to-2600m-3000m-vs-3343m-est

Bionano Genomics (NASDAQ:BNGO) lowers FY2025 sales outlook from $29.00 million-$32.00 million to $26.00 million-$30.00 million ...

 bionano-genomics-sees-q2-sales-6300m-6800m-vs-702m-est

Bionano Genomics (NASDAQ:BNGO) sees Q2 sales of $6.300 million-$6.800 million vs $7.02 million analyst estimate.

 bionano-genomics-q1-eps-115-beats-302-estimate-sales-650m-beat-623m-estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.15) per share which beat the analyst consensus estimate of $(3....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION